Figure 4. Latent phase anti-hCMV and EBV responses in healthy persons.
Antiviral responses were measured in 5 healthy individuals using a panel of 14 tetramers. (A) Diversity of responses per tetramer; number of responding clones and number of V/J-genes used. (B) Rank of most abundant clone of each tetramer in the CD8 population. Median rank is 16th (range 1st–106th). (C) Visualization of anti-hCMV and anti-EBV response in one HD using 9 tetramers.